Pharmacokinetics > Nova Content
The Center for Nanoscale Science and Technology at the National Institute of Standards and Technology (NIST) is working on creating complex nanostructures by taking... Read More »
Cases in which a newly approved drug is more effective than the cheaper alternatives already available are the exceptions rather than the rule. This is the conclusion ... Read More »
Researchers at the Polytechnic Institute of New York University have developed a new method for creating nanofibers out of proteins. These nanofibers can be used in a ... Read More »
At the turn of the new century, the Institute of Medicine (IOM) released a report titled, “To Err is Human: Building a Safer Health System”. Citing... Read More »
Researchers at Harvard University have developed a robotic device made from DNA that could potentially seek out specific cell targets within a complex mixture of ... Read More »
Researchers at Brigham and Women’s Hospital in Boston, Mass. have developed a new mechanism of drug release. It uses 3D superhydrophobic materials that make use ... Read More »
Researchers have discovered a brain mechanism that limits the rewarding sensations of cocaine. Recent research with rodents implicated histone deacetylases (HDACs)... Read More »
Researchers at the University of Buffalo (UB) have released results indicating that ORMOSIL (organically modified silica) nanoparticles could be used to deliver... Read More »
Bioengineers at Tufts University School of Engineering have developed a silk-based microneedle able to deliver precise drug amounts over a set time. In addition... Read More »
Researchers at Children’s Hospital Boston have created a new mathematical model that combines multiple forms of widely available data to predict adverse drug... Read More »
McKesson High Volume Solutions will introduce ExpressRx Track this week in New Orleans at the 46th American Society of Health-system Pharmacists Midyear Clinical... Read More »
BRUSSELS (Reuters) - Belgian biotech firm Ablynx said on Friday that it had regained the rights for its TNF-Alpha targeting nanobodies from Pfizer, which... Read More »
(Reuters) - U.S. health regulators approved on Friday the stroke preventer Xarelto from Bayer AG and Johnson & Johnson for people with a common heart rhythm... Read More »
Traditionally, drugs were discovered by identifying active ingredients in known remedies or through serendipitous discovery, such as penicillin. Currently, drug... Read More »
By Toni Clarke
(Reuters) - Biogen Idec Inc's said on Wednesday its experimental... Read More »
Bristol-Myers Squibb is combining its protease inhibitor Reyataz (atazanavir sulfate) with a pharmacoenhancing agent from Gilead Sciences Inc. called... Read More »
GENEVA (Reuters) - The World Intellectual Property Organization launched a consortium on Wednesday that would allow the public and private sector to... Read More »
LONDON (Reuters) - Two lung drugs being developed by Novartis and its British partner Vectura face delays in the United States, the... Read More »
(Reuters) - Smokers who take Pfizer's pill Chantix to help them quit do not have a higher risk of being hospitalized for psychiatric events such as... Read More »
(Reuters) - Exelixis Inc's drug to treat a rare form of thyroid cancer met the main goal of a late-stage study, prompting the company to look to an... Read More »